Patents by Inventor Julie MacRae

Julie MacRae has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11713301
    Abstract: Described herein is crystalline sodium (E)-2-(4-((3-(4-fluorophenyl)-3-(4-(3-morpholinoprop-1-yn-1-yl)phenyl)allyl)oxy)-2-methylphenoxy)acetate, uses of such crystalline material in the preparation of pharmaceutical compositions for the treatment of diseases or conditions that would benefit by administration with a PPAR? agonist compound.
    Type: Grant
    Filed: January 10, 2022
    Date of Patent: August 1, 2023
    Assignee: RENEO PHARMACEUTICALS, INC.
    Inventors: Susana Del Rio Gancedo, Osama Suleiman, Emma Sharp, Cristina Balogh, Rachael Lee, Julie Macrae, Neil Feeder
  • Patent number: 11267795
    Abstract: Described herein is crystalline sodium (E)-2-(4-((3-(4-fluorophenyl)-3-(4-(3-morpholinoprop-1-yn-1-yl)phenyl)allyl)oxy)-2-methylphenoxy)acetate, uses of such crystalline material in the preparation of pharmaceutical compositions for the treatment of diseases or conditions that would benefit by administration with a PPAR? agonist compound.
    Type: Grant
    Filed: July 20, 2021
    Date of Patent: March 8, 2022
    Assignee: RENEO PHARMACEUTICALS, INC.
    Inventors: Susana Del Rio Gancedo, Osama Suleiman, Emma Sharp, Cristina Balogh, Rachael Lee, Julie Macrae, Neil Feeder
  • Publication number: 20050032872
    Abstract: The present invention provides an improved process for the preparation of a polymorph of eletriptan hemisulphate.
    Type: Application
    Filed: May 24, 2004
    Publication date: February 10, 2005
    Inventors: Julian Aranda-Martinez, Catherine Dunne, Juergen Kleinschroth, Julie MacRae, Richard Storey, Ellen Weilbacher